関連する実験動画
Updated: Sep 9, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.0K
胸腺がんにおけるEMTと再発に関連している: 臨床病理学的研究
Hironobu Okada1, Yoshihiro Hayashi2, Naoki Furukawa3
1Department of Thoracic Surgery, Kochi Medical School, Nankoku, Kochi, Japan. jm-hironobu@kochi-u.ac.jp.
Medical molecular morphology
|September 1, 2025
まとめ
胸腺がんにおけるFascin-1高発現は,手術後の再発率の増加と相関する. このアクチン結合タンパク質は上皮-メゼンキマ移行 (EMT) と関連しており,潜在的な予後マーカーであることを示唆しています.
科学分野:
- 腫瘍学
- 細胞生物学
- 生物化学
背景:
- ファシン-1は,がん細胞の運動と侵入に不可欠なアクチン結合タンパク質です.
- 希少な悪性腫瘍である胸腺がんにおけるその役割はよく理解されていません.
- エピテリア・メゼンキマ移行 (EMT) は癌の進行における重要なプロセスです.
研究 の 目的:
- 胸腺がんにおけるFascin-1発現の臨床的関連性と予後的意義を調査する.
- 術後の再発とFascin-1,EMTマーカーの関連性を調べる
主な方法:
- 手術で切除された10例の胸腺がんの遡及的分析
- ファシン-1とEMTマーカー (TGF-β,pSmad3,スナイル,E-カデリン) の免疫ヒストロケミカル染色
- オールレッドスコアシステムと二重免疫光検査による評価
主要な成果:
- E- カデリンが少ない腫瘍部位で高Fascin- 1発現が観察された.
- ファシン-1はTGF-βやスナイルのようなEMT誘発マーカーと同局した.
- 術後再発した患者では,Fascin-1のスコアが著しく高かった (P=0. 048).
結論:
- 高Fascin-1発現はEMTと関連しており,胸腺癌の術後の再発の予後バイオマーカーとして機能する.
- Fascin-1は,胸腺がんの潜在的な治療標的である.
- より大きなコホートと機能研究でのさらなる検証が推奨されます.
関連する概念動画
Cadherins in Tissue Organization
3.1K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.1K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

